Speaker illustration

Doctor Satish Ramkumar

Monash Heart, Melbourne (Australia)

Member of:

European Society of Cardiology

Dr. Satish Ramkumar - MBBS, B Med Sci, MMed Dr Ramkumar is a cardiac research fellow at the Baker Heart and Diabetes Institute completing his PhD investigating atrial fibrillation risk assessment and the role of left atrial strain in risk assessment. He is currently completing dual physician training in cardiology and general medicine at Monash Medical centre, Melbourne, Australia. Following on from his clinical training, Dr. Ramkumar is keen to pursue advanced fellowship training in multi-modality cardiac imaging.

The mitral to aortic/pulmonary velocity-time integral ratio is a simple, feasible and accurate discriminator for echocardiographic evaluation of severe isolated mitral regurgitation.

Event: ESC Congress 2022

Topic: Valvular Heart Disease

Session: What is new in valvular heart disease assessed with echocardiography?


Impact of disease stage on performance of strain markers for prediction of atrial fibrillation

Event: ESC Congress 2019

Topic: Tissue Doppler, Speckle Tracking and Strain Imaging

Session: The role of imaging for pacing candidates and arrhythmias


Is the calibration method for central blood pressure important in assessing the association between central blood pressure with LV and left atrial strain?

Event: ESC Congress 2017

Topic: Haemodynamics, heart and hypertension

Session: Hypertension and haemodynamics


Use of left atrial strain for risk stratification in atrial fibrillation with low clinical thromboembolic risk.

Event: ESC Congress 2017

Topic: Stroke

Session: Stroke and Carotid disease


Prediction of heart failure and atrial fibrillation using the CHARGE-AF and ARIC risk scores.

Event: ESC Congress 2017

Topic: Diagnosis

Session: Chronic heart failure (CHF)


Comparison of outcomes between nonagenarian and younger patients undergoing transcatheter aortic valve replacement (TAVR) with the LOTUS valve.

Event: ESC Congress 2016

Topic: Percutaneous / endovascular treatment

Session: Percutaneous structural heart interventions


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb